DC bio-immune therapy of chronic hepatitis B to determine the efficacy of standard and therapeutic e

Determine the efficacy of the standard as follows:

     1. Cured: HBV-DNA, HBsAg and HBeAg were negative, liver function to normal.

     2. Better: HBV-DNA, HBsAg and HBeAg were significantly decreased or three indicators part of the overcast.

     3. Invalid: HBV-DNA, HBsAg and HBeAg concentrations had no significant decrease or increase.

     Our preliminary results show that, DC Biological Immune treatment of chronic hepatitis B virus infection of efficiency was 98%. Without taking into account the affordability of patient cases, no copy or a low level of viral replication who, the cure rate can reach 20-30%; virus replication in high-level persons, treatment before and during treatment with antiviral drugs, the application of rule The more the rate can reach 10-20%. Its efficient and high cure rate is unprecedented. As we treat the increasing accumulation of experience, biological immunity of the continuous improvement of experimental methods, as well as the combined application of antiviral drugs, we have the treatment of chronic hepatitis B virus-infected persons is expected to further increase the cure rate. http://www.tcmwell.com